Gerard Silvestri to Smoking
This is a "connection" page, showing publications Gerard Silvestri has written about Smoking.
Connection Strength
3.463
-
The Association between Smoking Abstinence and Mortality in the National Lung Screening Trial. Am J Respir Crit Care Med. 2016 Mar 01; 193(5):534-41.
Score: 0.296
-
Screening for Lung Cancer Using Low-Dose Computed Tomography. Are We Headed for DANTE's Paradise or Inferno? Am J Respir Crit Care Med. 2015 May 15; 191(10):1100-1.
Score: 0.280
-
Reply: Lung Cancer Screening: The Balance between Harm and Benefit. Am J Respir Crit Care Med. 2015 May 15; 191(10):1209-10.
Score: 0.280
-
Lung cancer screening. Am J Respir Crit Care Med. 2015 Jan 01; 191(1):19-33.
Score: 0.273
-
Current status of tobacco policy and control. J Thorac Imaging. 2012 Jul; 27(4):213-9.
Score: 0.230
-
Screening for lung cancer: it works, but does it really work? Ann Intern Med. 2011 Oct 18; 155(8):537-9.
Score: 0.217
-
The Master Settlement Agreement and its impact on tobacco use 10 years later: lessons for physicians about health policy making. Chest. 2010 Mar; 137(3):692-700.
Score: 0.195
-
Attitudes towards screening for lung cancer among smokers and their non-smoking counterparts. Thorax. 2007 Feb; 62(2):126-30.
Score: 0.156
-
One hundred years of lung cancer. Am J Respir Crit Care Med. 2005 Sep 01; 172(5):523-9.
Score: 0.141
-
Characteristics of Persons Screened for Lung Cancer in the United States : A Cohort Study. Ann Intern Med. 2022 Nov; 175(11):1501-1505.
Score: 0.117
-
Executive Summary: Screening for Lung Cancer: Chest Guideline and Expert Panel Report. Chest. 2021 11; 160(5):1959-1980.
Score: 0.107
-
Predicted impact of attaining smoking reduction goals on mortality. South Med J. 2001 Feb; 94(2):176-83.
Score: 0.104
-
Assessment of Integrated Classifier's Ability to Distinguish Benign From Malignant Lung Nodules: Extended Analyses and 2-Year Follow-Up Results of the PANOPTIC (Pulmonary Nodule Plasma Proteomic Classifier) Trial. Chest. 2021 03; 159(3):1283-1287.
Score: 0.102
-
Smoking Trends and Lung Cancer Mortality: The Good, the Bad, and the Ugly. Ann Intern Med. 2018 11 20; 169(10):721-722.
Score: 0.089
-
Tobacco Dependence Predicts Higher Lung Cancer and Mortality Rates and Lower Rates of Smoking Cessation in the National Lung Screening Trial. Chest. 2018 07; 154(1):110-118.
Score: 0.086
-
Factors Associated with a Positive Baseline Screening Exam Result in the National Lung Screening Trial. Ann Am Thorac Soc. 2016 09; 13(9):1568-74.
Score: 0.077
-
Lung cancer risk test trial: study design, participant baseline characteristics, bronchoscopy safety, and establishment of a biospecimen repository. BMC Pulm Med. 2016 Jan 22; 16:16.
Score: 0.074
-
A Bronchial Genomic Classifier for the Diagnostic Evaluation of Lung Cancer. N Engl J Med. 2015 Jul 16; 373(3):243-51.
Score: 0.070
-
Evaluation of the lung cancer risks at which to screen ever- and never-smokers: screening rules applied to the PLCO and NLST cohorts. PLoS Med. 2014 Dec; 11(12):e1001764.
Score: 0.068
-
Evaluating the effect of access to free medication to quit smoking: a clinical trial testing the role of motivation. Nicotine Tob Res. 2014 Jul; 16(7):992-9.
Score: 0.065
-
Attitudes and beliefs toward lung cancer screening among US Veterans. Chest. 2013 Dec; 144(6):1783-1787.
Score: 0.063
-
Selection criteria for lung-cancer screening. N Engl J Med. 2013 Feb 21; 368(8):728-36.
Score: 0.060
-
Invited commentary: the etiology of lung cancer in men compared with women. Am J Epidemiol. 2013 Apr 01; 177(7):613-6.
Score: 0.060
-
Cigarette smoking and the risk of dying from tobacco-related malignancies by race. Anticancer Res. 2011 Nov; 31(11):3891-5.
Score: 0.055
-
Screening for lung cancer in a high-risk group: but I still haven't found what I'm looking for... Eur Respir J. 2007 Jan; 29(1):6-7.
Score: 0.039
-
The Cost-Effectiveness of Nicotine Replacement Therapy Sampling in Primary Care: a Markov Cohort Simulation Model. J Gen Intern Med. 2022 11; 37(14):3684-3691.
Score: 0.028
-
Tobacco Treatment Specialist Training for Lung Cancer Screening Providers. Am J Prev Med. 2021 11; 61(5):765-768.
Score: 0.027
-
Primary Care Provider and Patient Perspectives on Lung Cancer Screening. A Qualitative Study. Ann Am Thorac Soc. 2016 11; 13(11):1977-1982.
Score: 0.019
-
Screening and early detection efforts in lung cancer. Cancer. 2015 May 01; 121(9):1347-56.
Score: 0.017
-
Cost-effectiveness of CT screening in the National Lung Screening Trial. N Engl J Med. 2014 Nov 06; 371(19):1793-802.
Score: 0.017
-
Targeting of low-dose CT screening according to the risk of lung-cancer death. N Engl J Med. 2013 Jul 18; 369(3):245-254.
Score: 0.015
-
U.S. primary care physicians' lung cancer screening beliefs and recommendations. Am J Prev Med. 2010 Nov; 39(5):411-20.
Score: 0.013
-
The risk of dying from lung cancer by race: a prospective cohort study in a biracial cohort in Charleston, South Carolina. Ann Epidemiol. 2009 May; 19(5):304-10.
Score: 0.011
-
Lung and bronchus cancer disparities in South Carolina: epidemiology and strategies for prevention. J S C Med Assoc. 2006 Aug; 102(7):183-91.
Score: 0.010